Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy
Anticancer Research · 2023
DOI: 10.21873/anticanres.16409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Masafumi Iguchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan; micloud@koto.kpu-m.ac.jp. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Mesenchymal Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan; micloud@koto.kpu-m.ac.jp.
- Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Pediatric Surgery, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Zitieren
APA
Iguchi, M., Yagyu, S., Kambe, K., Higashi, M., Fumino, S., Kishida, T., Iehara, T., Mazda, O., & Tajiri, T. (2023). Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy. Anticancer Research. https://doi.org/10.21873/anticanres.16409
Vancouver
Iguchi M, Yagyu S, Kambe K, Higashi M, Fumino S, Kishida T, et al. Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy. Anticancer Research. 2023. doi:10.21873/anticanres.16409
BibTeX
@article{Iguchi2023,
author = {Iguchi, Masafumi and Yagyu, Shigeki and Kambe, Kosuke and Higashi, Mayumi and Fumino, Shigehisa and Kishida, Tsunao and Iehara, Tomoko and Mazda, Osam and Tajiri, Tatsuro},
title = {Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16409}
}
EUVIMED